Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00502294
Status:
WITHDRAWN
Last Update Posted:
2009-06-25
First Post:
2007-07-13
Brief Title:
A Phase 3 Randomized Double-Blind Placebo-Controlled Multicenter Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis
Sponsor:
Facet Biotech
Organization:
Facet Biotech
Organization Data
Organization:
Facet Biotech
Class:
INDUSTRY
Study ID:
291-416
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Facet Biotech
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| PDL BioPharma Inc | INDUSTRY |